The added value of left atrial strain in cancer‐therapy‐related cardiac dysfunction
Authors:
- 8 March 2024
- journal article
- editorial
- Published by Wiley in Echocardiography
- Vol. 41 (3) , e15792
Abstract
No abstract availableKeywords
All Related Versions
This publication has 15 references indexed in Scilit:
- Left atrial strain is reduced following trastuzumab in breast cancer patientsEchocardiography, 2024
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- Left Atrial Strain changes in patients with breast cancer during anthracycline therapyInternational Journal of Cardiology, 2021
- Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2016
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2016
- Functional and Anatomic Responses of the Left Atrium to Change in Estimated Left Ventricular Filling PressureJournal of the American Society of Echocardiography, 2015
- Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillationEuropean Heart Journal - Cardiovascular Imaging, 2015
- Value of left atrial strain: a highly promising field of investigationEuropean Heart Journal - Cardiovascular Imaging, 2014
- Cardiovascular events, early discontinuation of trastuzumab, and their impact on survivalBreast Cancer Research and Treatment, 2014
- Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for CareCancer Epidemiology, Biomarkers & Prevention, 2013